P476: AN ORAL COMBINATION THERAPY OF OR-2100 AND VENETOCLAX IN ACUTE MYELOID LEUKEMIA

• Kazuharu Kamachi,
• Hiroshi Ureshino,
• Kazunori Kawasoe,
• Keisuke Kidoguchi,
• Yuta Yamamoto,
• Yuki Fukuda-Kurahashi,
• Yuki Kurahashi,
• Tatsuro Watanabe,
• Shinya Kimura

Affiliations

Kazuharu Kamachi

1 Saga University, Hematology, Respiratory Medicine and Oncology, Saga, Japan

Hiroshi Ureshino

1 Saga University, Hematology, Respiratory Medicine and Oncology, Saga, Japan

Kazunori Kawasoe

1 Saga University, Hematology, Respiratory Medicine and Oncology, Saga, Japan

Keisuke Kidoguchi

1 Saga University, Hematology, Respiratory Medicine and Oncology, Saga, Japan

Yuta Yamamoto

1 Saga University, Hematology, Respiratory Medicine and Oncology, Saga, Japan

Yuki Fukuda-Kurahashi

4 Saga University, Drug Discovery and Biomedical Sciences, Saga, Japan

Yuki Kurahashi

4 Saga University, Drug Discovery and Biomedical Sciences, Saga, Japan

Tatsuro Watanabe

4 Saga University, Drug Discovery and Biomedical Sciences, Saga, Japan

Shinya Kimura

1 Saga University, Hematology, Respiratory Medicine and Oncology, Saga, Japan